Dr. John Maris, Children's Hospital of Philadelohia Dr. Nai Kong Cheung, Memorial Sloan Kettering Cancer Center Dr. Patrick Reynolds, Children's Hospital of Los Angeles Dr. Susan Cohn, Univerisity of Chicago Dr. Darryl Yamashiro, Columbia University...

(TENTATIVE)      FRIDAY, JULY 18, 2008 SPEAKER TOPIC 9:00 AM Pat Tallungan Introduction 9:15 AM Dr. Sue Cohn Overview of neuroblastoma & intermediate risk study updates 10:30 AM Rebecca Mannis Hearing...

Hyatt Regency Woodfield Amenities Hyatt Regency Woodfield is a full service quality hotel located in the heart of the northern suburban business district. Among Schaumburg hotels, no other puts you closer to the experience of shopping and dining at...

The Conference The Kid's Room Hyatt Regency Woodfield Hotel Activities 2 swimming pools: indoor lap pool and seasonal outdoor pool Outdoor whirlpool (seasonal) Sundeck surrounding outdoor pool area Health club featuring a variety of cardiovascular...

Maps & Directions Hotel Address Hyatt Regency Woodfield 1800 East Golf Road,Schaumburg, Illinois, USA 60173 Tel: +1 847 605 1234    Fax: +1 847 605 0328 MapQuest  Directions From O'Hare International Airport (9 miles - 25...

July 17 – 20, 2008 Where:          Hyatt Regency Woodfield                     1800 East Golf Road                     Schaumburg,...

On March 18,2008 Dr. Heidi Russell spent a little over an hour speaking with families about neuroblastoma bone and bone marrow metastases. Dr. Russell is a leader among the neuroblastoma research community. One of her interests is in understanding how...

Pat Tallungan, President of the Children's Neuroblastoma Cancer Foundation, presents the introduction to the 2007 Children's Neuroblastoma Cancer Foundation's Neuroblastoma Conference June 29, 2007 in Chicago, Il....

Susan L. Cohn, M.D., Director of Clinical Research, Pediatric Hematology/Oncology at the University of Chicago presents an overview of neuroblastoma.  This presentation was made at the Children's Neuroblastoma Cancer Foundation's Neuroblastoma Conference...

Dr. Peter Adamson, Chief, Division of Clinical Pharmacology and Therapeutics Director, Experimental Therapeutics in Oncology, The Children’s Hospital of Philadelphia provides an overview of the clinical trial process. This presentation was made at the...

Dr. Kate Matthay, Division Chief, Pediatric Hematology/Oncology, UCSF and Leader, NANT Consortium presents current NANT protocols, study rationale, and information regarding the NANT and phase 1 trials. This presentation was made at the Children's Neuroblastoma...

James G. Gurney, Ph.D. University of Minnesota, provided an overview of his long-term survivor study issues for children with neuroblastoma. This presentation was made at the Children's Neuroblastoma Cancer Foundation's Neuroblastoma Conference on June...

Stephen A. Sands, Psy.D. is an Assistant Professor in Pediatrics and Psychiatry at the Columbia University Medical Center. He also serves as the Director of the Valerie Fund Psycho-Social Program at the Herbert Irving Child and Adolescent Oncology Center....

Dr. Patrick Reynolds, MD PhD, Director, Developmental Therapeutics Program, USC / CHLA Institute for Pediatric Clinical Research provides an overview of the neuroblastoma research process to help the public understand research data and how it should...

Heidi V. Russell, M.D. Assistant Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine and study chair of the NANT trial “A Phase I Study of Zoledronic Acid (Zometa) with Cyclophosphamide in Children with Recurrent/Refractory...

Giselle Sholler, M.D., Assistant Professor of Pediatrics, Vermont Cancer Center, University of Vermont, presents her preclinical and clinical data regarding Nifurtimox and its potential use in the treatment of neuroblastoma. This presentation was made...

Wendy Mitchell M.D., Neurology Division, Childrens Hospital Los Angeles discusses Opsoclonus-Ataxia Syndrome and its relationship to neuroblastoma. This presentation was made at the Children's Neuroblastoma Cancer Foundation's Neuroblastoma Conference...

Clare Twist, M.D., Associate Professor, Department of Pediatrics – Hematology / Oncology, Stanford School of Medicine. She is the Study Chair for the current COG Phase III Study for the treatment of children with Intermediate Risk Neuroblastoma. I am...

Stephan A. Grupp, MD, PhD, Attending physician; Medical Director, Stem Cell Laboratory, Children’s Hospital of Philadelphia presents the upcoming COG phase III transplant study and discusses various transplant related research. This presentation was...

Erik Ludwinski shares his story about his journey through the world of neuroblastoma....

Molly Hollway, Neuroblastoma Stage III Cancer Survivor...

Mark Dungan provides an overview of Lunch for Life and other programs for the CNCF. Pat Tallungan thanks all of the oncologists and families for their participation....